Lamc2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth.
Oihane EriceShruthi NarayananIker FeliuRodrigo Entrialgo-CadiernoAntonia MalinovaCaterina VicentiniElisabeth GuruceagaPietro DelfinoMarija Trajkovic-ArsicHaritz MorenoKarmele ValenciaEster BlancoIrati MacayaDaniel ÖhlundPurvesh KhatriFernando LecandaAldo ScarpaJens Thomas SivekeVincenzo CorboMariano Ponz-SarviséSilvestre VincentPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
LAMC2 is a molecular target in PDAC which regulates a transcriptional network that unveils a dual drug combination for cancer treatment.